CREO Creo Medical Group PLC
10.20GBp+2.51%Mkt Cap: 49.80M $P/E: —Today
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an ener…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap49.80M USD
Enterprise Value40.10M USD
Revenue (TTM)7.61M USD
Gross Profit2.61M USD
Net Income (TTM)5.76M USD
Revenue/Share0.02 GBp
Last Price10.20 GBp
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees104
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-7.15
PEG—
EV/EBITDA-2.18
EV/Revenue5.27
P/S6.19
P/B0.80
EPS (TTM)-0.10
EPS (Forward)-0.01
52W Range
0.000055% of range18.50
52W High18.50 GBp
52W Low0.0000 GBp
Profitability
Gross Margin40.00%
Oper. Margin-228.13%
EBITDA Margin-241.43%
Profit Margin88.33%
ROE10.60%
ROA8.97%
Growth
Revenue Growth45.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.76M USD
CapEx (TTM)978.26K USD
FCF Margin-174.11%
FCF Yield-26.60%
Net Debt-3.80M USD
Net Debt/EBITDA0.21
Balance Sheet
Debt/Equity0.08
Current Ratio2.79
Quick Ratio2.33
Book Value/Sh0.12 GBp
Cash/Share0.02 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 GBp
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)55.00 GBp
Upside (mean)+439.2%
Target Range40.00 GBp – 70.00 GBp
40.00+439.2% to mean70.00
# Analysts2
Ownership
Shares Out.449.14M
Float383.36M
Insiders6.94%
Institutions45.41%
Technical
SMA 5012.55 (-18.7%)
SMA 20013.09 (-22.1%)
Beta0.91
S&P 52W Chg14.58%
Avg Vol (30d)796.69K
Avg Vol (10d)1.60M
Technical Indicators
RSI (14)24.1
MACD-0.7310
MACD Signal-0.5127
MACD Hist.-0.2183
BB Upper13.77 GBp
BB Middle11.70 GBp
BB Lower9.633 GBp
BB Width35.35%
ATR (14)0.5746 GBp
Vol Ratio (20d)0.69x